{
    "code": "02023206",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023206",
    "time": "2022-04-15 04:02:28",
    "許可證字號": "衛署藥輸字第023206號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/06\/18",
    "發證\/登錄日期": "90\/06\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202320601",
    "中文品名": "愛妥糖錠３０公絲",
    "英文品名": "ACTOS TABLETS 30MG",
    "適應症": "第２型糖尿病患者（非胰島素依賴型糖尿病，ＮＩＤＤＭ）。",
    "劑型": "110錠劑",
    "包裝": "鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PIOGLITAZONE HYDROCHLORIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "620118P360  台灣賽特瑞恩有限公司",
    "申請商地址": "臺北市信義區松仁路97號3樓之1",
    "主製造廠": [
        {
            "": "JAPAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6133061413  歐帕生技醫藥股份有限公司",
            "製造廠廠址": "新竹縣湖口鄉光復路1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝及分裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6820400910",
            "成分名稱": "PIOGLITAZONE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "33.0600000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "30",
        "標記二": "武田2,391"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Actos 30mg 外觀-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023206&Seq=437&Type=10"
        },
        {
            "title": "02023206.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023206&Seq=436&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Actos_TW_20211105-111-01-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023206&Seq=124&Type=9"
        },
        {
            "title": "PDF_B_for_Insert_for_Actos_TW_91233223.rev1_20210809-110-11-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023206&Seq=123&Type=9"
        },
        {
            "title": "PI_Actos (中文)_(201808)_R22-TPC Hikari (病人)-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023206&Seq=122&Type=9"
        },
        {
            "title": "愛妥糖錠-仿單-107-09-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023206&Seq=121&Type=9"
        },
        {
            "title": "TW_Actose_30mg_CN_r1_technical approved-111-01-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023206&Seq=005&Type=8"
        },
        {
            "title": "Actos 30mg 30T(181002)-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023206&Seq=004&Type=8"
        },
        {
            "title": "020232060003.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023206&Seq=003&Type=8"
        }
    ]
}